ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1568

Distribution of Proteinuria in Scleroderma Renal Crisis: A Multi-Center Study

Arifa Javed1, Lilit Grigoryan2, Alex Luta3, Sumbal Wajid2, Lee Shapiro4, Virginia Steen5 and Swati Mehta6, 1Albany Medical Center, Rensselaer, NY, 2Albany Medical Center, Albany, NY, 3MedStar Georgetown University Hospital, Rockville, MD, 4Albany Medical College, Stillwater, NY, 5Georgetown University School of Medicine, Washington, DC, 6Division of Nephrology, Department of Medicine, Albany Medical Center, Albany, NY

Meeting: ACR Convergence 2024

Keywords: Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Scleroderma renal crisis (SRC) is a rare but life-threatening complication of systemic sclerosis (SSc), characterized by malignant hypertension and acute kidney injury (AKI). Proteinuria when present at the time of SRC is usually observed to be mild and less than 2 grams/day. However, there is a paucity of data examining the distribution of proteinuria in SRC. In this analysis, we aim to examine the distribution of proteinuria in patients at the time of SRC and look at the correlation of proteinuria with creatinine.

Methods: We retrospectively obtained data from two centers: Albany Medical Center and Medstar Georgetown University Hospital, of patients with proteinuria during SRC between 2004-2018. Proteinuria was defined as spot urine protein-to-creatinine ratio (UPCR) equal to or exceeding 0.3 mg/mg. The spot UPCR roughly correlates to the 24-hour protein excretion (g/day/1.73 m2). Histogram and scattered plot were obtained showing distribution of proteinuria and correlation with renal function respectively.

Results: A total of 60 patients with SRC were included from the two centers. 19/60 patients had spot UPCR ratio that was checked at the time of SRC diagnosis and of these, all had proteinuria as defined above. 74% (14/19) of the cohort had UPCR < 2 mg/mg while 26% (5/19) had > 2 mg/mg (Fig 1). The median UPCR in the cohort was 1.2 mg/mg. There was no correlation between proteinuria and creatinine (Fig 2).

Mean age was 52 years and 89% (17/19) were females. The majority of the cohort (58 %,11/19) was Caucasian. The mean duration of SSc was 3 years. None of these patients had alternate causes of proteinuria such as diabetes mellitus (DM). Pulmonary involvement was most commonly observed. 53% (9/17) patients had positive anti-RNA polymerase III (Table 1). All the patients were managed with angiotensin converting enzyme inhibitor (ACE inhibitor). One-third of patients required hemodialysis at the time of diagnosis of SRC. 26% (5/18) remained dialysis-dependent at the end of 1 year.

Conclusion: Proteinuria is common in SRC. While most data suggest that proteinuria < 2 grams is commonly seen in SRC, our analysis indicates that levels exceeding 2 grams can also occur. However, this finding is limited by the small sample size and selection bias of those patients for whom UPCR was checked. Further, there was absence of 24-hour urine protein collections to corroborate the data. A future study would be helpful to further investigate this.

Supporting image 1

Table 1: Demographics and clinical characteristics of patients with proteinuria

Supporting image 2

Figure 1: Histogram showing distribution of UPCR in the SRC.

Supporting image 3

Figure 2: Scatterplot showing distribution of UPCR compared to creatinine.


Disclosures: A. Javed: None; L. Grigoryan: None; A. Luta: None; S. Wajid: None; L. Shapiro: None; V. Steen: None; S. Mehta: None.

To cite this abstract in AMA style:

Javed A, Grigoryan L, Luta A, Wajid S, Shapiro L, Steen V, Mehta S. Distribution of Proteinuria in Scleroderma Renal Crisis: A Multi-Center Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/distribution-of-proteinuria-in-scleroderma-renal-crisis-a-multi-center-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distribution-of-proteinuria-in-scleroderma-renal-crisis-a-multi-center-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology